铁化剂诱导的伪氧激活了肺癌中的瘤免疫反应
Yusuke Hamada1, Toshiaki Ohara1, Yuehua Chen1
1Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Free radical research
|August 24, 2025
概括
铁剂如SP10诱导虚氧,增强对瘤的免疫反应. 这种方法可以增强T细胞功能,并与肺癌治疗的PD-1疗法协同作用.
科学领域:
- 免疫学
- 癌症学
- 分子生物学
背景情况:
- 低氧诱导因子 (HIF) 信号传递对免疫细胞功能至关重要.
- 铁剂可以诱导铁中介的HIF-1α稳定.
研究的目的:
- 通过调节瘤免疫反应来研究铁剂是否增强抗瘤作用.
- 阐明铁剂诱导的抗瘤活性背后的机制.
主要方法:
- 使用铁化剂超多10 (SP10) 和德胺 (DFO) 来诱导缺铁和伪缺氧.
- 评估T细胞和非小细胞肺癌 (NSCLC) 细胞系的IL-2分泌量 (A549,PC-3,LLC).
- 评估了SP10对C57BL/ 6和免疫缺陷RAG1缺陷小鼠的LLC瘤生长的影响,以及其与PD-1抗体治疗的协同作用.
主要成果:
- 铁剂诱导的伪低氧刺激了T细胞和NSCLC细胞系的IL-2分泌.
- 在免疫能力较强的小鼠中,SP10可减少LCL瘤的生长,但在免疫缺陷小鼠中却不能.
- 在实验室中,SP10并没有直接抑制癌细胞的增殖,这表明它具有免疫作用.
- 通过增加瘤透淋巴细胞 (TILs),SP10协同增强了PD-1抗体治疗的疗效.
结论:
- 铁化诱导的伪缺氧通过HIF-1α上调激活抗瘤免疫反应.
- 这一过程增加了T细胞功能和IL-2分泌,提高了PD-1抗体治疗的疗效.
相关概念视频
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


